FindTrial
Sign In

A prospective randomized clinical study of treatment modality after operation for low risk early-stage cervical squamous cell carcinoma

A prospective randomized clinical study of treatment modality after operation for low risk early-stage cervical squamous cell carcinoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003070
Enrollment
Unknown
Registered
2013-01-14
Start date
2013-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical carcinoma

Interventions

Radiation:Pelvic radiotherapy+ Intracavitary radiotherapy
adjuvant chemotherapy + intracavitary radiotherapy:chemotherapy + intracavitary radiotherapy
concurrent chemoradiation:concurrent chemoradiation

Sponsors

Shandong Cancer Hospital & Institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. FIGO stage Ia–IIacervical squamous cell carcinoma; 2. Underwent radical hysterectomy and pelvic lymphadenectomy; 3. Patients with 1-2 the following low risk factors: deep stromal invasion (DSI), lymph vascular space involvement(LVSI), and tumor diameter>=4 cm; 4. KPS>=70; 5. With informed consents.

Exclusion criteria

Exclusion criteria: 1. Actualized chemotherapy or radiotherapy before operation; 2. Chemotherapy contraindication.

Design outcomes

Primary

MeasureTime frame
complication;—

Contacts

Public ContactSheng Xiugui
jnsxg@hotmail.com+86 13608921932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026